US drug shortages compared to the World Health Organization’s Model List of Essential Medicines for Children: A cross-sectional study
Authors:
- 1 August 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 79 (22) , 2012-2017
Abstract
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. To describe US drug shortages affecting medications on the 2019 World Health Organization (WHO) Model List of Essential Medicines for Children (EMLc). Drug shortage data from January 2014 to December 2019 were obtained from the University of Utah Drug Information Service. Shortage data for drugs on the EMLc were analyzed for the type of drug, American Hospital Formulary Service category, reason for the shortage, duration of the shortage, marketing status (generic vs brand name), and whether the agent was a single- or multisource drug. From 2014 to 2019, a total of 209 drug shortages impacted medications on the EMLc, of which 77 (36.8%) remained unresolved by 2019. Of all active shortages, 13 (6.2%) began before 2014. Resolved shortages had a median duration of 5.9 months (interquartile range [IQR], 3.6-13.2 months) while active shortages had a median duration of 18.3 months (IQR, 10.9-33.5 months; P ≤ 0.0001). The therapeutic categories most impacted by drug shortages were anti-infective agents (27.3%), central nervous system agents (12.9%), and antineoplastic agents (11.0%). The reason for the shortage was not reported in 46.4% of cases. When a reason was provided, the most common reason was manufacturing problems (29.2%) followed by supply/demand mismatch (15.8%). US drug shortages affected many medications on the WHO EMLc. Future studies should examine the global shortage climate and implications for patient care.Keywords
This publication has 14 references indexed in Scilit:
- Access to insulin: applying the concept of security of supply to medicinesBulletin of the World Health Organization, 2019
- Prescription Drug ShortagesPediatric Emergency Care, 2019
- ASHP guidelines on managing drug product shortagesAmerican Journal of Health-System Pharmacy, 2018
- Prescription Drug Shortages: Implications for Ambulatory PediatricsThe Journal of Pediatrics, 2018
- Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: An evaluation from multi-country surveys and stakeholder interviewsPLOS Medicine, 2017
- Longitudinal Trends in U.S. Drug Shortages for Medications Used in Emergency Departments (2001–2014)Academic Emergency Medicine, 2015
- Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global ReportingPLOS ONE, 2015
- Impact of Drug Shortages on Health System Pharmacies in the Southeastern United StatesHospital Pharmacy, 2015
- Critical Drug Shortages: Implications for Emergency MedicineAcademic Emergency Medicine, 2014
- Chemotherapy Drug Shortages in Pediatric Oncology: A Consensus StatementPediatrics, 2014